Clinical

Dataset Information

0

SWARM_Systemic release of growth factors after radioembolization of hepatic malignancies


ABSTRACT: Interventions: Group 1: The radioembolization in hepatic malignancies is a routine clinical procedure. Serum samples for growth factor determination from peripheral venous blood are taken at three points in time - before therapy, after the first radioembolization and before the second radioembolization. Study procedure ends after the third blood sample has been taken. The second therapy for SIRT and the follow-up examinations belong to the scope of routine clinical procedures/follow-up. Primary outcome(s): Evaluation of growth hormone release as a prognostic marker for overall survival after local ablative radioembolization therapy (SIRT) of hepatic malignancies. Study Design: Allocation: N/A: single arm study; Masking: Open (masking not used); Control: uncontrolled; Assignment: single; Study design purpose: basic science

DISEASE(S): Secondary Malignant Neoplasm Of Small Intestine,Breast, Unspecified,Secondary Malignant Neoplasm Of Liver And Intrahepatic Bile Duct,Secondary Malignant Neoplasm Of Large Intestine And Rectum,Liver Cell Carcinoma

PROVIDER: 2721073 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2019-12-24 | GSE131482 | GEO
2021-03-23 | GSE168457 | GEO
| 2243903 | ecrin-mdr-crc
| 18242 | ecrin-mdr-crc
2017-03-22 | GSE95793 | GEO
2011-12-01 | E-GEOD-33987 | biostudies-arrayexpress
2021-09-08 | PXD017508 | Pride
| EGAD00001010104 | EGA
2020-06-23 | GSE48295 | GEO
| 2360780 | ecrin-mdr-crc